Berman Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.51M Buy
20,163
+1,935
+11% +$147K 0.24% 50
2021
Q2
$1.42M Buy
18,228
+7,778
+74% +$579K 0.23% 56
2021
Q1
$767K Buy
10,450
+1,343
+15% +$99.1K 0.16% 66
2020
Q4
$709K Buy
9,107
+63
+0.7% +$4.82K 0.17% 62
2020
Q3
$713K Sell
9,044
-326
-3% -$25.5K 0.2% 57
2020
Q2
$689K Sell
9,370
-2,726
-23% -$205K 0.18% 58
2020
Q1
$885K Buy
12,096
+1,571
+15% +$123K 0.29% 39
2019
Q4
$911K Buy
10,525
+51
+0.5% +$4.19K 0.26% 42
2019
Q3
$839K Buy
10,474
+169
+2% +$13.5K 0.26% 41
2019
Q2
$819K Buy
10,305
+679
+7% +$52K 0.26% 43
2019
Q1
$761K Sell
9,626
-237
-2% -$17.7K 0.25% 45
2018
Q4
$718K Buy
9,863
+4,379
+80% +$309K 0.28% 39
2018
Q3
$356K Sell
5,484
-1,397
-20% -$89K 0.15% 69
2018
Q2
$393K Buy
6,881
+716
+12% +$40.4K 0.14% 70
2018
Q1
$320K Buy
+6,165
New +$333K 0.12% 75

Other funds holding MRK

Berman Capital Advisors's MRK Position: Q3 2021 in Review

Berman Capital Advisors increased its Merck (MRK) stake by 11% in Q3 2021, buying an estimated $147K and bringing the position to 20,163 shares worth $1.51M. The position accounts for 0.24% of the portfolio, ranked #50.

Berman Capital Advisors first reported a position in MRK in Q1 2018 and has held it in 15 quarters since. 2,648 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

  • Berman Capital Advisors held 20,163 shares of Merck worth $1.51M as of Q3 2021.
  • Berman Capital Advisors bought 1,935 Merck shares in Q3 2021, an estimated $147K.
  • Merck made up 0.24% of Berman Capital Advisors's portfolio in Q3 2021, its #50 holding.
  • Berman Capital Advisors first reported a position in Merck in Q1 2018 and has held it in 15 quarters since.
  • 2,648 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.